Cytokines as Biomarkers in Chronic Oral Graft-Versus-Host Disease
Author Information
Author(s): Pugliese Giorgia, Nitro Letizia, Allevi Fabiana, Biglioli Federico, Coccapani Matilde, Felisati Giovanni, Ferella Francesco, Ghilardi Giorgio, Montavoci Linda, Caretti Anna, Saibene Alberto Maria
Primary Institution: Università degli Studi di Milano
Hypothesis
Can serum and salivary cytokines serve as reliable biomarkers for chronic graft-versus-host disease (cGVHD)?
Conclusion
IL-17 could be a potential biomarker for cGVHD-related inflammation, while salivary samples do not seem to be reliable for diagnosis.
Supporting Evidence
- IL-17 levels were significantly elevated in the serum of cGVHD patients compared to LPO patients and controls.
- IL-6 and IL-1α did not show significant differences among the groups.
- Salivary samples did not reach statistical significance in cytokine levels among the three groups.
Takeaway
This study looked at whether certain proteins in blood and saliva can help doctors tell if someone has a specific disease called cGVHD. They found one protein, IL-17, might be helpful, but saliva tests aren't reliable.
Methodology
A prospective cohort study comparing serum and salivary cytokine levels in cGVHD patients, LPO patients, and healthy controls using ELISA and statistical tests.
Potential Biases
Potential bias due to the small sample size and the specific patient population studied.
Limitations
The small sample size limits the conclusions, and the study did not include patients with acute GVHD.
Participant Demographics
The study included 19 females and 11 males with a median age of 63 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website